Robert Califf addressed a range of issues, including AI, lack of nutrition resources at the FDA and how he evaluates the progress of precision medicine at the Precision Medicine World Conference in ...
In 2025, primary care practices must navigate a landscape filled with hidden costs that threaten both financial stability and quality of care. From fragmented systems to increasing clinician and ...
In a new brief, the Purchaser Business Group on Health called for policy changes that address healthcare costs and improve access to high-quality care.
The DEA recently released three rules regarding the remote prescribing of controlled substances. However, many telehealth ...
There is a dearth of professionals with licenses and training to provide care for seniors’ mental and behavioral health challenges — such as Alzheimer's and other dementias, anxiety and ...
Drugs that activate the GLP-1 receptor transformed the treatment of obesity, but biotech company Metsera contends that limitations keep them from expanding their reach. The weekly injections and ...
When I look back on my journey, I’m reminded of how much can change when you are able to ask for, and receive, help. My name is Dr. Christopher Schenewerk. I am a physician, a father, and a ...
While large-molecule therapeutics capture most headlines, small-molecule drugs face significant challenges, struggling with funding cuts, supply chain disruptions, and growing demand. At the same ...
Organizations are integrating previously disparate services to better align their offerings with the shift from fee-for-service to risk-based care through visionary, member-centric solutions.
A novel Vertex Pharmaceuticals drug that takes a new approach to pain is now approved by the FDA, a landmark decision for a first-in-class product that brings patients a treatment alternative ...
Welcome back to another episode of MedCity FemFwd, a podcast dedicated to discussing the breakthroughs and challenges in women’s health. In this episode, we’re joined by Emily Lindemer, an ...